{"id":34225,"date":"2018-02-01T09:25:33","date_gmt":"2018-02-01T14:25:33","guid":{"rendered":"http:\/\/www.ottawahospital.on.ca\/?p=34225"},"modified":"2022-12-14T11:34:29","modified_gmt":"2022-12-14T16:34:29","slug":"molecular-testing-helped-cancer-patient-get-clinical-trial","status":"publish","type":"post","link":"https:\/\/www.ottawahospital.on.ca\/en\/healthy-tomorrows\/molecular-testing-helped-cancer-patient-get-clinical-trial\/","title":{"rendered":"Molecular testing helped cancer patient get into clinical trial"},"content":{"rendered":"<p style=\"text-align: center;\"><em>Patient Cathy Chapman (left) and her sister, Enid Holohan, discussed her clinical trial treatment with Clinical Research Coordinator Saara Ali (right).<\/em><\/p>\n<p>Chemotherapy wasn\u2019t working for Cathy Chapman. However, a genetic test identified a specific gene mutation that meant she could take part in a new cancer drug trial.<\/p>\n<p>Chapman was diagnosed with colon cancer in February 2017. She began chemotherapy at The Ottawa Hospital\u2019s satellite clinic in Pembroke, since she lives in Deep River. However, the chemotherapy did nothing but give her side effects. The cancer continued growing, so her treatment stopped in April 2017.<\/p>\n<p>Meanwhile, The Ottawa Hospital\u2019s Molecular Oncology Diagnostics Laboratory analyzed Chapman\u2019s tumour and identified a gene mutation that offered another treatment option. Only about five percent of colon cancers have this mutation. Dr. Bryan Lo, director of the molecular lab, flagged the mutation to Chapman\u2019s oncologist, Dr. Rachel Goodwin.<\/p>\n<p>Dr. Goodwin knew about an upcoming international clinical trial at The Ottawa Hospital Cancer Centre for a drug that was having great success with Chapman\u2019s specific sub-type of colon cancer. The drug was designed to block the mutation and slow down the cancer growth.<\/p>\n<div id=\"attachment_34221\" style=\"width: 310px\" class=\"wp-caption alignnone\"><img decoding=\"async\" aria-describedby=\"caption-attachment-34221\" class=\"size-medium wp-image-34221\" src=\"https:\/\/www.ottawahospital.on.ca\/wp-content\/uploads\/2018\/01\/Molecular-Photo-2-Dr.-Rachel-Goodwin-300x200.jpg\" alt=\"image of Dr. Rachel Goodwin\" width=\"300\" height=\"200\" srcset=\"https:\/\/www.ottawahospital.on.ca\/wp-content\/uploads\/2018\/01\/Molecular-Photo-2-Dr.-Rachel-Goodwin-300x200.jpg 300w, https:\/\/www.ottawahospital.on.ca\/wp-content\/uploads\/2018\/01\/Molecular-Photo-2-Dr.-Rachel-Goodwin-600x400.jpg 600w, https:\/\/www.ottawahospital.on.ca\/wp-content\/uploads\/2018\/01\/Molecular-Photo-2-Dr.-Rachel-Goodwin-768x512.jpg 768w, https:\/\/www.ottawahospital.on.ca\/wp-content\/uploads\/2018\/01\/Molecular-Photo-2-Dr.-Rachel-Goodwin-1024x683.jpg 1024w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><p id=\"caption-attachment-34221\" class=\"wp-caption-text\">Oncologist Dr. Rachel Goodwin identified a clinical trial that would treat Cathy Chapman\u2019s rare type of colon cancer.<\/p><\/div>\n<p>Chapman was the first patient in Canada on this international trial.<\/p>\n<p>In 2016, the molecular lab began analyzing the genetic makeup of colon cancer tumours using its new Next Generation Sequencer (purchased entirely with donor support). By identifying the genetic makeup of each person\u2019s individual tumour, oncologists can tailor the cancer treatment to be more effective for them.<\/p>\n<p>\u201cWhen we get the genetic sequencing report back for a colon cancer patient, we might see that the patient has a gene mutation that could make their cancer susceptible to a drug we never would have considered, like a kidney cancer drug, or to a new drug,\u201d said Dr. Goodwin. This was the case with 60-year-old Chapman.<\/p>\n<p>\u201cBecause there is currently no drug being used as a standard of care for her type of colon cancer, Cathy could get the drug only on a trial,\u201d said Dr. Goodwin. \u201cThat is why we take the efforts to open new trials here with new drugs to provide patients like Cathy with up and coming treatments.\u201d<\/p>\n<div id=\"attachment_34222\" style=\"width: 310px\" class=\"wp-caption alignnone\"><img decoding=\"async\" aria-describedby=\"caption-attachment-34222\" class=\"wp-image-34222 size-medium\" src=\"https:\/\/www.ottawahospital.on.ca\/wp-content\/uploads\/2018\/01\/Molecular-Photo-3-Cathy-Chapman_SNO_0248-300x200.jpg\" alt=\"image of Cathy Chapman (patient)\" width=\"300\" height=\"200\" srcset=\"https:\/\/www.ottawahospital.on.ca\/wp-content\/uploads\/2018\/01\/Molecular-Photo-3-Cathy-Chapman_SNO_0248-300x200.jpg 300w, https:\/\/www.ottawahospital.on.ca\/wp-content\/uploads\/2018\/01\/Molecular-Photo-3-Cathy-Chapman_SNO_0248-600x400.jpg 600w, https:\/\/www.ottawahospital.on.ca\/wp-content\/uploads\/2018\/01\/Molecular-Photo-3-Cathy-Chapman_SNO_0248-768x512.jpg 768w, https:\/\/www.ottawahospital.on.ca\/wp-content\/uploads\/2018\/01\/Molecular-Photo-3-Cathy-Chapman_SNO_0248-1024x683.jpg 1024w, https:\/\/www.ottawahospital.on.ca\/wp-content\/uploads\/2018\/01\/Molecular-Photo-3-Cathy-Chapman_SNO_0248.jpg 1600w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><p id=\"caption-attachment-34222\" class=\"wp-caption-text\">Cathy Chapman visits The Ottawa Hospital Cancer Centre for weekly treatments as part of a clinical trial.<\/p><\/div>\n<p>\u201cCathy wasn\u2019t doing so well on her other treatments, so the timing was perfect that this trial was coming up,\u201d said Saara Ali, Clinical Research Coordinator. \u201cThanks to the molecular testing done by Dr. Lo and the networking between him, Dr. Goodwin, and myself, we were able to put forward this new patient for this clinical trial as a treatment option.\u201d<\/p>\n<p>\u201cI was randomized into the trial, which gives me multiple drugs,\u201d said Chapman, who drives to the Cancer Centre at the General Campus once a week for treatment. \u201cWithin several doses, the CT scan showed a reduction in my cancer. The tumour shrank 40 percent after I was on the clinical trial for seven weeks. In December, a CT scan showed it had shrunk 63 percent.\u201d<\/p>\n<p>\u201cShe\u2019s at full dose and doing well on it,\u201d said Ali. \u201cAs long as she is benefitting, the drugs will be provided for her through the clinical trial.\u201d<\/p>\n<p>The molecular lab is prepared to identify mutations in the genetic profile of other patients with this rare mutation, so they might also take part in the trial and benefit from trying innovative and untested therapies.<\/p>\n<p>The Ottawa Hospital is <a href=\"https:\/\/ohfoundation.ca\/campaign-to-create-tomorrow\/world-leading-research\/\">raising funds<\/a> that are critical for research studies and clinical trials in order to bring better treatments to patients as soon as they are available.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Chemotherapy wasn\u2019t working for Cathy Chapman. However, a genetic test identified a specific gene mutation that meant she could take part in a new international cancer drug trial \u2013 the first patient in Canada.<\/p>\n","protected":false},"author":25,"featured_media":34224,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[9],"tags":[13,281,92],"class_list":["post-34225","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthy-tomorrows","tag-cancer","tag-clinical-trials","tag-research"],"acf":[],"wps_subtitle":"","_links":{"self":[{"href":"https:\/\/www.ottawahospital.on.ca\/en\/wp-json\/wp\/v2\/posts\/34225","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ottawahospital.on.ca\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ottawahospital.on.ca\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ottawahospital.on.ca\/en\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ottawahospital.on.ca\/en\/wp-json\/wp\/v2\/comments?post=34225"}],"version-history":[{"count":0,"href":"https:\/\/www.ottawahospital.on.ca\/en\/wp-json\/wp\/v2\/posts\/34225\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ottawahospital.on.ca\/en\/wp-json\/wp\/v2\/media\/34224"}],"wp:attachment":[{"href":"https:\/\/www.ottawahospital.on.ca\/en\/wp-json\/wp\/v2\/media?parent=34225"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ottawahospital.on.ca\/en\/wp-json\/wp\/v2\/categories?post=34225"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ottawahospital.on.ca\/en\/wp-json\/wp\/v2\/tags?post=34225"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}